Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Inflammation, apoptosis, and necrosis induced by neoadjuvant fas ligand gene therapy improves survival of dogs with spontaneous bone cancer.

Modiano JF, Bellgrau D, Cutter GR, Lana SE, Ehrhart NP, Ehrhart E, Wilke VL, Charles JB, Munson S, Scott MC, Pozniak J, Carlson CS, Schaack J, Duke RC.

Mol Ther. 2012 Dec;20(12):2234-43. doi: 10.1038/mt.2012.149. Epub 2012 Jul 31.

2.

Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins.

Haller AA, Lauer GM, King TH, Kemmler C, Fiolkoski V, Lu Y, Bellgrau D, Rodell TC, Apelian D, Franzusoff A, Duke RC.

Vaccine. 2007 Feb 9;25(8):1452-63. Epub 2006 Nov 10.

PMID:
17098335
3.

Yeasts encoding tumour antigens in cancer immunotherapy.

Franzusoff A, Duke RC, King TH, Lu Y, Rodell TC.

Expert Opin Biol Ther. 2005 Apr;5(4):565-75. Review.

PMID:
15934834
4.

Mutation-selective tumor remission with Ras-targeted, whole yeast-based immunotherapy.

Lu Y, Bellgrau D, Dwyer-Nield LD, Malkinson AM, Duke RC, Rodell TC, Franzusoff A.

Cancer Res. 2004 Aug 1;64(15):5084-8.

5.
6.

Enhancing antimelanoma immune responses through apoptosis.

Bianco SR, Sun J, Fosmire SP, Hance K, Padilla ML, Ritt MG, Getzy DM, Duke RC, Withrow SJ, Lana S, Matthiesen DT, Dow SW, Bellgrau D, Cutter GR, Helfand SC, Modiano JF.

Cancer Gene Ther. 2003 Sep;10(9):726-36.

PMID:
12944992
7.

Murine heart transgenic Fas ligand expression protects against allograft rejection.

Zuraff-Perryman LA, Duke RC, Setser E, Nelson DP, Bellgrau D.

Transplant Proc. 2002 Dec;34(8):3396-8. No abstract available.

PMID:
12493481
8.

Regulation of Fas-mediated apoptosis by N-ras in melanoma.

Urquhart JL, Meech SJ, Marr DG, Shellman YG, Duke RC, Norris DA.

J Invest Dermatol. 2002 Sep;119(3):556-61.

9.

Reversible resistance to apoptosis in cutaneous T cell lymphoma.

Meech SJ, Edelson R, Walsh P, Norris DA, Duke RC.

Ann N Y Acad Sci. 2001 Sep;941:46-58. Review.

PMID:
11594582
10.

Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity.

Stubbs AC, Martin KS, Coeshott C, Skaates SV, Kuritzkes DR, Bellgrau D, Franzusoff A, Duke RC, Wilson CC.

Nat Med. 2001 May;7(5):625-9.

PMID:
11329066
11.

Methods of analyzing chromatin changes accompanying apoptosis of target cells in killer cell assays.

Duke RC.

Methods Mol Biol. 2000;121:125-43. Review. No abstract available.

PMID:
10818722
12.

Proinflammatory consequences of transgenic fas ligand expression in the heart.

Nelson DP, Setser E, Hall DG, Schwartz SM, Hewitt T, Klevitsky R, Osinska H, Bellgrau D, Duke RC, Robbins J.

J Clin Invest. 2000 May;105(9):1199-208.

13.

Apoptosis and CD95 ligand in immune privileged sites.

Bellgrau D, Duke RC.

Int Rev Immunol. 1999;18(5-6):547-62. Review. No abstract available.

PMID:
10672501
15.

Three-dimensional spheroid cultures of human prostate cancer cell lines.

Hedlund TE, Duke RC, Miller GJ.

Prostate. 1999 Nov 1;41(3):154-65.

PMID:
10517873
16.

NF-kappaB functions as both a proapoptotic and antiapoptotic regulatory factor within a single cell type.

Lin B, Williams-Skipp C, Tao Y, Schleicher MS, Cano LL, Duke RC, Scheinman RI.

Cell Death Differ. 1999 Jun;6(6):570-82.

17.

Transplantation of cells and tissues expressing Fas ligand.

Duke RC, Newell E, Schleicher M, Meech S, Bellgrau D.

Transplant Proc. 1999 May;31(3):1479-81. No abstract available.

PMID:
10330975
18.

Adenovirus-mediated expression of Fas ligand induces apoptosis of human prostate cancer cells.

Hedlund TE, Meech SJ, Srikanth S, Kraft AS, Miller GJ, Schaack JB, Duke RC.

Cell Death Differ. 1999 Feb;6(2):175-82.

19.

Newly discovered role for Fas ligand in the cell-cycle arrest of CD4+ T cells.

Desbarats J, Duke RC, Newell MK.

Nat Med. 1998 Dec;4(12):1377-82.

PMID:
9846574
20.

Adenoviral-mediated gene transfer in lymphocytes.

Leon RP, Hedlund T, Meech SJ, Li S, Schaack J, Hunger SP, Duke RC, DeGregori J.

Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):13159-64.

21.

Fas-mediated apoptosis in seven human prostate cancer cell lines: correlation with tumor stage.

Hedlund TE, Duke RC, Schleicher MS, Miller GJ.

Prostate. 1998 Jul 1;36(2):92-101.

PMID:
9655261
22.

Toxoplasma gondii-infected cells are resistant to multiple inducers of apoptosis.

Nash PB, Purner MB, Leon RP, Clarke P, Duke RC, Curiel TJ.

J Immunol. 1998 Feb 15;160(4):1824-30.

23.

Human keratinocytes maintain reversible anti-apoptotic defenses in vivo and in vitro.

Norris DA, Middleton MH, Whang K, Schleicher M, McGovern T, Bennion SD, David-Bajar K, Davis D, Duke RC.

Apoptosis. 1997;2(2):136-48.

PMID:
14646548
24.

Cell suicide in health and disease.

Duke RC, Ojcius DM, Young JD.

Sci Am. 1996 Dec;275(6):80-7. No abstract available.

PMID:
8923763
25.

Differential effects of staphylococcal toxic shock syndrome toxin-1 on B cell apoptosis.

Hofer MF, Newell K, Duke RC, Schlievert PM, Freed JH, Leung DY.

Proc Natl Acad Sci U S A. 1996 May 28;93(11):5425-30.

26.

HIV gp120-specific cell-mediated immune responses in mice after oral immunization with recombinant Salmonella.

Berggren RE, Wunderlich A, Ziegler E, Schleicher M, Duke RC, Looney D, Fang FC.

J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Dec 15;10(5):489-95.

PMID:
8548327
27.

A role for CD95 ligand in preventing graft rejection.

Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC.

Nature. 1995 Oct 19;377(6550):630-2. Erratum in: Nature 1998 Jul 9;394(6689):133.

PMID:
7566174
28.

Macrophage colony-stimulating factor complementary DNA: a candidate for gene therapy in metastatic melanoma.

Walsh P, Dorner A, Duke RC, Su LJ, Glode LM.

J Natl Cancer Inst. 1995 Jun 7;87(11):809-16.

PMID:
7791230
29.
30.

Cytolysis mediated by ionophores and pore-forming agents: role of intracellular calcium in apoptosis.

Duke RC, Witter RZ, Nash PB, Young JD, Ojcius DM.

FASEB J. 1994 Feb;8(2):237-46.

PMID:
8119494
31.

Apoptosis in cytotoxic T lymphocytes and their targets.

Duke RC.

Semin Immunol. 1992 Dec;4(6):407-12. Review.

PMID:
1286167
32.

Apoptosis and programmed cell death in immunity.

Cohen JJ, Duke RC, Fadok VA, Sellins KS.

Annu Rev Immunol. 1992;10:267-93. Review.

PMID:
1590988
33.

The 1991 Albert Lasker Public Service Award. Women's reproductive health. A chronic crisis.

Duke RC, Speidel JJ.

JAMA. 1991 Oct 2;266(13):1846-7. No abstract available.

PMID:
1890715
34.

Stimulation by superantigen.

Cohen CJ, Duke RC, Sellins KS.

Nature. 1991 Jul 18;352(6332):199-200. No abstract available.

PMID:
1857413
35.

Apoptosis: a general comment.

Alles A, Alley K, Barrett JC, Buttyan R, Columbano A, Cope FO, Copelan EA, Duke RC, Farel PB, Gershenson LE, et al.

FASEB J. 1991 May;5(8):2127-8. No abstract available.

PMID:
2022310
36.

Purified perforin induces target cell lysis but not DNA fragmentation.

Duke RC, Persechini PM, Chang S, Liu CC, Cohen JJ, Young JD.

J Exp Med. 1989 Oct 1;170(4):1451-6.

38.

Cytotoxic lymphocyte-derived lytic granules do not induce DNA fragmentation in target cells.

Duke RC, Sellins KS, Cohen JJ.

J Immunol. 1988 Oct 1;141(7):2191-4.

PMID:
2844898
39.

Cellular and molecular immunology of tissue transplantation.

La Rosa FG, Talmage DW, Zlotnik A, Duke RC.

Revis Biol Celular. 1988;17:1-114. Review. No abstract available.

PMID:
3071826
40.
41.
42.

DNA fragmentation in targets of CTL: an example of programmed cell death in the immune system.

Cohen JJ, Duke RC, Chervenak R, Sellins KS, Olson LK.

Adv Exp Med Biol. 1985;184:493-508. Review. No abstract available.

PMID:
2994413
43.
44.

Endogenous endonuclease-induced DNA fragmentation: an early event in cell-mediated cytolysis.

Duke RC, Chervenak R, Cohen JJ.

Proc Natl Acad Sci U S A. 1983 Oct;80(20):6361-5.

45.

Health services and the family planning component.

Epstein SG, Chen PC, Grant JP, Duke RC, Guttmacher L, Oakley D.

Draper Fund Rep. 1980 Mar;8:5-9.

PMID:
12261798

Supplemental Content

Support Center